the likelihood of developing the disease. In DeLisi and Bertisch’s (2006) study on schizophrenia, 71% of persons with affected family members would take preventive medicine, as would 56% of clinical psychiatrists (100% would prescribe it), and 45% of psychiatric genetic researchers (52% would prescribe it). Of note, while early intervention seems promising, there is no guarantee that early medication will change the outcome for schizophrenia (Corcoran et al., 2005). These finding should be interpreted cautiously: the study of a large sample of participants of direct-to-consumer testing for non-psychiatric disorders concluded that few changes in lifestyle or behavior resulted from the testing, confirming the difficulty of motivating behavioral changes. (Bloss et al., 2011)
